Temporal linguistic shifts in oncology randomized controlled trials following large language model availability: A corpus analysis of 21,392 publications

European Journal of Cancer · Published 2026-07-24 · DOI 10.1016/j.ejca.2026.116963

Free full text

Authors (2)

Amina Regina Silva, Vanessa Silva e Silva

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Silva, A., Silva, V. (2026). Temporal linguistic shifts in oncology randomized controlled trials following large language model availability: A corpus analysis of 21,392 publications. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116963

Related articles

• Will the widespread use of large language models in scientific writing undermine scientists’ critical thinking? · PLOS Biology · 2026 · Cites or is cited by this article
• Navigating Evidence Standards: Stakeholder Perspectives on External Controls and Randomization in Cancer Trials · Asia-Pacific Journal of Clinical Oncology · 2026 · Cites or is cited by this article
• Risk of recurrence of stage I to III melanoma in Norway, 2008–2022 · European Journal of Cancer · 2026 · Same journal
• The clinical relevance of regional lymph node microarchitecture in oesophageal cancer patients – Results from the UK MRC OE02 trial · European Journal of Cancer · 2026 · Same journal
• Time-dependent recurrence patterns after curative resection for stage II/III colorectal cancer: An integrated analysis of four phase III randomized controlled trials (JCOG2310A-S4) · European Journal of Cancer · 2026 · Same journal
• Letter-to-the-editor Re: “Associations between early loss of skeletal muscle and osimertinib trough concentrations in patients with advanced EGFR-mutated NSCLC” · European Journal of Cancer · 2026 · Same journal
• Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial · European Journal of Cancer · 2026 · Same journal
• Hold the line: Local control strategies in oligoprogressive gynecologic cancers during systemic therapy · European Journal of Cancer · 2026 · Same journal
• Tumor treating fields: Will the evidence gap ever be filled? · European Journal of Cancer · 2026 · Same journal
• Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience · European Journal of Cancer · 2026 · Same journal